Published in J Urol on June 18, 2009
From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol (2011) 1.01
TRPA1 mediates bladder hyperalgesia in a mouse model of cystitis. Pain (2014) 0.91
TRPV1: A Potential Drug Target for Treating Various Diseases. Cells (2014) 0.91
TRPV4 as a target for bladder overactivity. F1000 Biol Rep (2010) 0.77
Acid-sensing ion channels ASIC2 and ASIC3 do not contribute to mechanically activated currents in mammalian sensory neurones. J Physiol (2004) 2.48
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A (2003) 2.29
P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol (2005) 2.25
Pharmacology of P2X channels. Pflugers Arch (2006) 2.14
Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. Am J Physiol Regul Integr Comp Physiol (2009) 2.11
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79
Pivotal role of nucleotide P2X2 receptor subunit of the ATP-gated ion channel mediating ventilatory responses to hypoxia. J Neurosci (2003) 1.59
ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest (2005) 1.58
P2X receptors and their role in female idiopathic detrusor instability. J Urol (2002) 1.36
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol (2004) 1.26
Peristalsis is impaired in the small intestine of mice lacking the P2X3 subunit. J Physiol (2003) 1.13
ATP modulation of excitatory synapses onto interneurons. J Neurosci (2003) 1.10
P2X2 subunits contribute to fast synaptic excitation in myenteric neurons of the mouse small intestine. J Physiol (2003) 1.10
RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents. J Pharmacol Exp Ther (2012) 1.09
RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists. Br J Pharmacol (2006) 1.08
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist. Br J Pharmacol (2010) 1.07
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain (2010) 1.06
Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. Physiol Genomics (2012) 1.05
ATP and P2X purinoceptors in urinary tract disorders. Handb Exp Pharmacol (2011) 1.03
Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol (2006) 1.03
ATP-gated ion channels mediate adaptation to elevated sound levels. Proc Natl Acad Sci U S A (2013) 1.02
Enhanced thermal avoidance in mice lacking the ATP receptor P2X3. Pain (2005) 1.02
Expression and function of rat urothelial P2Y receptors. Am J Physiol Renal Physiol (2008) 1.01
Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunit. J Neurosci (2004) 0.97
Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Mol Immunol (2013) 0.93
Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice. J Mol Cell Cardiol (2013) 0.93
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain. Bioorg Med Chem Lett (2009) 0.90
Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Arthritis Res Ther (2013) 0.90
Facilitatory interplay in alpha 1a and beta 2 adrenoceptor function reveals a non-Gq signaling mode: implications for diversification of intracellular signal transduction. Mol Pharmacol (2008) 0.88
The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res (2014) 0.88
Developmentally regulated expression of the P2X3 receptor in the mouse cochlea. Histochem Cell Biol (2005) 0.87
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain. Bioorg Med Chem Lett (2009) 0.86
An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats. Br J Pharmacol (2002) 0.86
Endogenous purinergic control of bladder activity via presynaptic P2X3 and P2X2/3 receptors in the spinal cord. J Neurosci (2010) 0.85
The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception. Neurosci Lett (2008) 0.84
Physiologic and molecular characterization of a murine model of right ventricular volume overload. Am J Physiol Heart Circ Physiol (2013) 0.83
Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in rats. J Urol (2007) 0.82
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models. J Med Chem (2012) 0.81
Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate. Br J Pharmacol (2004) 0.79
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist. Bioorg Med Chem Lett (2009) 0.79
Effect of neurokinins on canine prostate cell physiology. Prostate (2005) 0.78
Pharmacological and functional characterization of bradykinin B2 receptor in human prostate. Eur J Pharmacol (2004) 0.77
Identification of P2X receptors in cultured mouse and rat parasympathetic otic ganglion neurones including P2X knockout studies. Neuropharmacology (2004) 0.77
P2Y receptor regulation of cultured rat cerebral cortical cells: calcium responses and mRNA expression in neurons and glia. Br J Pharmacol (2003) 0.76
miR-21 is associated with fibrosis and right ventricular failure. JCI Insight (2017) 0.75
Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modification. Bioorg Med Chem Lett (2005) 0.75